Conference Coverage

Conference Coverage

Ublituximab depletes B cells in phase 2 trial

DALLAS – The investigational therapy may allow for lower doses and shorter infusion times, compared with available anti-CD20 treatments.

Conference Coverage

CSF biomarker clusters correlate with MS severity

DALLAS – Proteins related to astrocytes and microglia are elevated in the CSF of patients with multiple sclerosis and correlate with MS disease...

Pages